# New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

> **NCT06525688** · — · RECRUITING · sponsor: **National and Kapodistrian University of Athens** · enrollment: 60 (estimated)

## Conditions studied

- Osteoporosis, Postmenopausal
- Osteoporosis Fracture
- Osteoporosis, Severe

## Interventions

- **OTHER:** Bone, Serum and Plasma sample

## Key facts

- **NCT ID:** NCT06525688
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-03
- **Primary completion:** 2024-10-15
- **Final completion:** 2025-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06525688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06525688, "New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06525688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*